Mirtazapine
Product Images NDC 64725-1117

2 FDA label images from Tya Pharmaceuticals · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Mirtazapine (NDC 64725-1117). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Tya Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (64725 1117)

Label Image (64725 1117)
The label for Mirtazapine 15 mg tablets, packaged as 30 count per bottle. It is marked Rx only, with manufacturer listed as Watson and repackaged by T.Y.A Pharmaceuticals in Tallahassee, FL. The label includes a barcode and a note to see the package insert for dosing information.*
FDA Label Image

Chemical Structure (Mirtazapine Tablets 1)

Chemical Structure (Mirtazapine Tablets 1)
Chemical structure diagram of Mirtazapine, depicting its molecular framework with rings and nitrogen atoms, consistent with its chemical composition.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.